期刊文献+

左氧氟沙星热敏型耳用凝胶的制备及其性能检测 被引量:5

Preparation of levofloxacin thermosensitive otic gel and its characteristic property test analysis
下载PDF
导出
摘要 目的制备左氧氟沙星热敏型耳用凝胶,并对其体外释放性能进行检测。方法制备以泊洛沙姆407为基质的左氧氟沙星热敏性耳用凝胶,根据中耳温度筛选泊洛沙姆407的最佳处方浓度,采用立式Franz扩散池模型对该制剂的体外释放性能进行研究。结果左氧氟沙星检测浓度的线性范围为3.0~10.5mg/L,在此浓度范围内吸光度(A)和浓度(C)呈良好的线性关系,即C(mg/L)=12.582A+0.2976(r=0.9986,n=6);平均回收率为100.09%,相对标准偏差(RSD)=0.61%(n=6);泊洛沙姆407在处方中的最佳浓度为17%;药物释放具有一定的控释性,释放符合零级动力学特征。结论该耳用热敏型凝胶具有较好的控释性能,且制备方法简单,用药剂量易于控制。 Objective To prepare the levofloxacin(LEF) thermosensitive gel for otitis drug delivery, and to detect the characteristic properties of the drug release in vitro. Methods Poloxamer 407 was studied as themosensitive material for the LEF ear drop. The best prescription concentration of poloxamer was selected according to the temperature of gel. The Franz vertical diffusion cell method was used to study the drug release. Results The detected concentration of LEF was in the linear range of 3.0 - 10.5 mg/L, and in this range the concentration(C) had a well linear relationship with absorbance (A): C (mg/L) = 12.582A +0.2976(r =0.9986,n =6). The average rate of recovery was 100.09% and the relative standard deviation (RSD) = 0.61% (n = 6). The best concentration of poloxamer in prescription was 17%. The drug possessed the characteristic properties of controlled release, and the release followed zero-order kinetics. Conclusions Levoflocacin thermosensitive otic gel possessed the characteristic properties of controlled release, and the preparation was simple in method and easy to control in dosage.
出处 《中国眼耳鼻喉科杂志》 2012年第5期285-288,共4页 Chinese Journal of Ophthalmology and Otorhinolaryngology
关键词 左氧氟沙星 泊洛沙姆407 热敏型耳用凝胶 体外释放 立式扩散池法 Levofloxacin Poloxamer 407 Thermosensitive gel for otitis drug delivery Drug release in vitro Vertical diffusion cell method
  • 相关文献

参考文献6

  • 1Ma WD, Xu H, Wang C, et al. Pluronic F127-g-poly ( acrylic acid) co- polymers as in situ gelling vehicle for ophthalmic drug delivery system[J]. Int J Pharm,2008,350(1/2) :247-256.
  • 2Fawaz F, Koffi A, Guyot M , et al. Comparative in vitro-in vivo study of two quinine rectal gel formulations [ J ]. Int J Pharm ,2004,280 (1/2) : 151-162.
  • 3徐玉红,曾繁涛,王蔓琳,李玉珍,刘新宇,李成.甲硝唑阴道用原位凝胶的处方设计及体外质量评价[J].中国药师,2008,11(9):1025-1027. 被引量:11
  • 4Sakamoto T, Nakagawa T, Horie RT, et al. Inner ear drug delivery system from the clinical point of view[ J ]. Acta Otolaryngol Suppl, 2010, 130(2) :101-104.
  • 5Blonde JM, Baird L, Fulls JC, et al. Dose-dependent hyperlipidemia in rabbits following administration of poloxamer 407 gel [ J ]. Life Sci, 1999,65 (21) :261-266.
  • 6Lee SH, Lee JE, Back WY, et al. Regional delivery of vancomycin using pluronic F-127 to inhibit methicillin resistant Staphylococcus au- reus(MRSA) growth in chronic otitis media in vitro and in vivo [ J ]. J Control Release ,2004,96 ( 1 ) : 1-7.

二级参考文献9

共引文献10

同被引文献37

  • 1王志钢,王艳姣,李慧,臧琛,张保献.丹葛明目即型凝胶的制备研究[J].中国中药杂志,2012,37(1):46-51. 被引量:14
  • 2宋涛,王东凯,高红,张翠霞,纪标.利巴韦林鼻用温敏凝胶热力学和流变学性质研究[J].中国医药工业杂志,2006,37(8):540-542. 被引量:29
  • 3Garov EV, Antonian RG, Sheremet AS, et al. The retrospective clinical study of labyrinthine fistula associated with chronic suppurative otitis media and their treatment [ J ]. Vestn Otorinolaringol, 2012 (5) :20-26.
  • 4Sakamoto T, Nakagawa T, Horie RT, et al. Inner ear drug delivery system from the clinical point of view [ J ]. Acta Otolaryngol Suppl, 2010,130 (2) :101-104.
  • 5MacArthur C J, Trune DR. Mouse models of otitis media [ J ]. Curr Opin Otolaryngol Head Neck Surg, 2006,14 (5) :341-346.
  • 6Adoga AA, Bakari A, Afolabi OA, et al. Bacterial isolates in chronic suppurative otitis media: a changing pattern? [ J ]. Niger J Med, 2011, 20(1):96-98.
  • 7Shim HJ, Park CH, Kim MG, et al. A pre- and postoperative bacteriological study of chronic suppurative otitis media [ J]. Infection, 2010, 38(6):447452.
  • 8Park DC, Lee SK, Cha C1, et al. Antimicrobial resistance of Staphylococcus from otorrhea in chronic suppurative otitis media and comparison with results of all isolated Staphylococci [J]. EurJ Clin Microbiol Infect Dis, 2008, 27 (7) :571-577.
  • 9Yeo SG, Park DC, Hong SM, et al. Bacteriology of chronic suppurative otitis media--a multicenter study [ J]. Acta Otolaryngol, 2007,127 (10) :1062-1067.
  • 10Blonder JM, Baird L, Fulfs JC, et al. Dose-dependent hyperlipidemia in rabbits following administration of poloxamer 407 gel [ J ]. Life Sci, 1999,65 ( 21 ) :261-266.

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部